- Home
- MYFW vs LYEL Comparison
MYFW vs LYEL Comparison
Compare MYFW & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- LYEL
- Stock Information
- Founded
- MYFW 2002
- LYEL 2018
- Country
- MYFW United States
- LYEL United States
- Employees
- MYFW N/A
- LYEL N/A
- Industry
- MYFW Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- LYEL Health Care
- Exchange
- MYFW Nasdaq
- LYEL Nasdaq
- Market Cap
- MYFW 170.9M
- LYEL 203.9M
- IPO Year
- MYFW 2018
- LYEL 2021
- Fundamental
- Price
- MYFW $19.57
- LYEL $0.70
- Analyst Decision
- MYFW Buy
- LYEL Sell
- Analyst Count
- MYFW 3
- LYEL 2
- Target Price
- MYFW $21.83
- LYEL $1.00
- AVG Volume (30 Days)
- MYFW 26.6K
- LYEL 1.3M
- Earning Date
- MYFW 04-17-2025
- LYEL 03-03-2025
- Dividend Yield
- MYFW N/A
- LYEL N/A
- EPS Growth
- MYFW N/A
- LYEL N/A
- EPS
- MYFW 0.26
- LYEL N/A
- Revenue
- MYFW $79,649,000.00
- LYEL $63,000.00
- Revenue This Year
- MYFW N/A
- LYEL N/A
- Revenue Next Year
- MYFW $10.84
- LYEL N/A
- P/E Ratio
- MYFW $75.18
- LYEL N/A
- Revenue Growth
- MYFW N/A
- LYEL N/A
- 52 Week Low
- MYFW $12.84
- LYEL $0.51
- 52 Week High
- MYFW $22.32
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- MYFW 42.09
- LYEL 64.48
- Support Level
- MYFW $20.60
- LYEL $0.57
- Resistance Level
- MYFW $21.70
- LYEL $0.63
- Average True Range (ATR)
- MYFW 0.62
- LYEL 0.05
- MACD
- MYFW -0.16
- LYEL 0.02
- Stochastic Oscillator
- MYFW 2.80
- LYEL 87.86
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.